Caption Management’s Praxis Precision Medicines PRAX Stock Holding History

Caption Management’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.9M	Sell	9,000 -1,000	-10%	-$309K	0.02%	709
2025 Q4	$2.95M	Sell	10,000 -33,500	-77%	-$6.24M	0.02%	695
2025 Q3	$2.31M	Buy	+43,500	New	+$2.11M	0.02%	791
2025 Q2	–	Sell	-173,200	Closed	-$6.56M	–	1808
2025 Q1	$6.56M	Buy	173,200 +117,500	+211%	+$7.34M	0.06%	305
2024 Q4	$4.29M	Sell	55,700 -3,900	-7%	-$282K	0.04%	411
2024 Q3	$3.43M	Sell	59,600 -126,700	-68%	-$6.84M	0.05%	396
2024 Q2	$7.71M	Buy	+186,300	New	+$8.8M	0.12%	184

Other funds holding PRAX

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Caption Management's PRAX Position: Q1 2026 in Review

Caption Management sold out of Praxis Precision Medicines (PRAX) in Q1 2026, closing a stake of 33,300 shares — an estimated $10.3M sold.

Caption Management first reported a position in PRAX in Q3 2024 and held it in 5 quarters. The position peaked at $9.81M in Q4 2025. 289 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

Caption Management reported no remaining Praxis Precision Medicines position as of Q1 2026 after selling out during the quarter.
Caption Management sold 33,300 Praxis Precision Medicines shares in Q1 2026, an estimated $10.3M.
Caption Management first reported a position in Praxis Precision Medicines in Q3 2024 and held it in 5 quarters.
Caption Management's Praxis Precision Medicines position peaked at $9.81M in Q4 2025.
289 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.